For covid-19 research, for covid-19 research, invivomab anti-mouse PD-L1 (1000 MG), catalog# BE0101, quantity: 1 @ #13,650.00 EA.
Ended Purchase Order Awarded
- Contract number
- 75N93022P00014
- Awardee
-
Bio X Cell, LLC UEI RCAAGKSC77R3
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $13,750
Award facts
- Contract value 100% obligated
- $13,750.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- West Lebanon, Lebanon, NH 03784, USA
- National interest action
- Coronavirus COVID-19
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract 75N93022P00014?
75N93022P00014 was awarded to Bio X Cell, LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on October 18, 2021.
How much is contract 75N93022P00014 worth?
The government has obligated $13,750 on 75N93022P00014.
Was contract 75N93022P00014 competed?
The extent of competition for 75N93022P00014 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award